264 related articles for article (PubMed ID: 30224239)
1. Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells.
Legros N; Pohlentz G; Steil D; Müthing J
Int J Med Microbiol; 2018 Dec; 308(8):1073-1084. PubMed ID: 30224239
[TBL] [Abstract][Full Text] [Related]
2. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.
Legros N; Dusny S; Humpf HU; Pohlentz G; Karch H; Müthing J
Glycobiology; 2017 Jan; 27(1):99-109. PubMed ID: 27558838
[TBL] [Abstract][Full Text] [Related]
3. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
[TBL] [Abstract][Full Text] [Related]
4. Expression of Shiga toxin 2e glycosphingolipid receptors of primary porcine brain endothelial cells and toxin-mediated breakdown of the blood-brain barrier.
Meisen I; Rosenbrück R; Galla HJ; Hüwel S; Kouzel IU; Mormann M; Karch H; Müthing J
Glycobiology; 2013 Jun; 23(6):745-59. PubMed ID: 23431059
[TBL] [Abstract][Full Text] [Related]
5. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.
Steil D; Schepers CL; Pohlentz G; Legros N; Runde J; Humpf HU; Karch H; Müthing J
J Lipid Res; 2015 Dec; 56(12):2322-36. PubMed ID: 26464281
[TBL] [Abstract][Full Text] [Related]
6. Enterohemorrhagic
Detzner J; Pohlentz G; Müthing J
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805890
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and influence of D-PDMP on synthesis and distribution of glycosphingolipid receptors.
Legros N; Pohlentz G; Runde J; Dusny S; Humpf HU; Karch H; Müthing J
Glycobiology; 2017 Oct; 27(10):947-965. PubMed ID: 28535204
[TBL] [Abstract][Full Text] [Related]
9. Primary Human Renal Proximal Tubular Epithelial Cells (pHRPTEpiCs): Shiga Toxin (Stx) Glycosphingolipid Receptors, Stx Susceptibility, and Interaction with Membrane Microdomains.
Detzner J; Klein AL; Pohlentz G; Krojnewski E; Humpf HU; Mellmann A; Karch H; Müthing J
Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437399
[TBL] [Abstract][Full Text] [Related]
10. Primary Human Colon Epithelial Cells (pHCoEpiCs) Do Express the Shiga Toxin (Stx) Receptor Glycosphingolipids Gb3Cer and Gb4Cer and Are Largely Refractory but Not Resistant towards Stx.
Detzner J; Püttmann C; Pohlentz G; Humpf HU; Mellmann A; Karch H; Müthing J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576167
[TBL] [Abstract][Full Text] [Related]
11. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells.
Betz J; Bauwens A; Kunsmann L; Bielaszewska M; Mormann M; Humpf HU; Karch H; Friedrich AW; Müthing J
Biol Chem; 2012 Mar; 393(3):133-47. PubMed ID: 22718629
[TBL] [Abstract][Full Text] [Related]
12. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
13. Shiga Toxins: An Update on Host Factors and Biomedical Applications.
Liu Y; Tian S; Thaker H; Dong M
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852
[TBL] [Abstract][Full Text] [Related]
14. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.
Bauwens A; Betz J; Meisen I; Kemper B; Karch H; Müthing J
Cell Mol Life Sci; 2013 Feb; 70(3):425-57. PubMed ID: 22766973
[TBL] [Abstract][Full Text] [Related]
15. Real-time interaction analysis of Shiga toxins and membrane microdomains of primary human brain microvascular endothelial cells.
Detzner J; Steil D; Pohlentz G; Legros N; Humpf HU; Mellmann A; Karch H; Müthing J
Glycobiology; 2020 Feb; 30(3):174-185. PubMed ID: 31691795
[TBL] [Abstract][Full Text] [Related]
16. Thin-Layer Chromatography in Structure and Recognition Studies of Shiga Toxin Glycosphingolipid Receptors.
Detzner J; Pohlentz G; Müthing J
Methods Mol Biol; 2021; 2291():229-252. PubMed ID: 33704756
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.
Betz J; Bielaszewska M; Thies A; Humpf HU; Dreisewerd K; Karch H; Kim KS; Friedrich AW; Müthing J
J Lipid Res; 2011 Apr; 52(4):618-34. PubMed ID: 21252262
[TBL] [Abstract][Full Text] [Related]
18. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.
Pacheco AR; Lazarus JE; Sit B; Schmieder S; Lencer WI; Blondel CJ; Doench JG; Davis BM; Waldor MK
mBio; 2018 Jun; 9(3):. PubMed ID: 29921669
[TBL] [Abstract][Full Text] [Related]
19. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
[TBL] [Abstract][Full Text] [Related]
20. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
Detzner J; Pohlentz G; Müthing J
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
